These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38979993)

  • 1. Consensus recommendations for optimising the diagnosis and treatment of paroxysmal nocturnal haemoglobinuria in Singapore.
    Goh YT; Yap ES; Tan CW; Tan D; Loh YSM; Lee YS; Chong LL; Lim ZY; Than H
    Ann Acad Med Singap; 2024 Jun; 53(6):371-385. PubMed ID: 38979993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Spanish consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria].
    Villegas A; Arrizabalaga B; Bonanad S; Colado E; Gaya A; González A; Jarque I; Núñez R; Ojeda E; Orfao A; Ribera JM; Vicente V; Urbano-Ispizua Á;
    Med Clin (Barc); 2016 Mar; 146(6):278.e1-7. PubMed ID: 26895645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How I treat paroxysmal nocturnal hemoglobinuria.
    Brodsky RA
    Blood; 2021 Mar; 137(10):1304-1309. PubMed ID: 33512400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of paroxysmal nocturnal haemoglobinuria: a personal view.
    Luzzatto L; Gianfaldoni G; Notaro R
    Br J Haematol; 2011 Jun; 153(6):709-20. PubMed ID: 21517820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors and follow-up parameters in patients with paroxysmal nocturnal hemoglobinuria (PNH): experience of the Austrian PNH network.
    Füreder W; Sperr WR; Heibl S; Zebisch A; Pfeilstöcker M; Stefanzl G; Jäger E; Greiner G; Schwarzinger I; Kundi M; Keil F; Hoermann G; Bettelheim P; Valent P
    Ann Hematol; 2020 Oct; 99(10):2303-2313. PubMed ID: 32856141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pegcetacoplan: A Review in Paroxysmal Nocturnal Haemoglobinuria.
    Heo YA
    Drugs; 2022 Dec; 82(18):1727-1735. PubMed ID: 36459381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How we('ll) treat paroxysmal nocturnal haemoglobinuria: diving into the future.
    Risitano AM; Peffault de Latour R
    Br J Haematol; 2022 Jan; 196(2):288-303. PubMed ID: 34355382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of pregnancy in paroxysmal nocturnal hemoglobinuria on long-term eculizumab.
    Vekemans MC; Lambert C; Ferrant A; Saussoy P; Havelange V; Debiève F; Van Den Neste E; Michaux L
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):464-6. PubMed ID: 25688464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expert consensus on clonal screening and monitoring of complement inhibitor therapy in paroxysmal nocturnal hemoglobinuria (2024)].
    Red Blood Cell Diseases (Anemia) Group, Chinese Society of Hematology, Chinese Medical Association
    Zhonghua Xue Ye Xue Za Zhi; 2024 Feb; 45(2):109-114. PubMed ID: 38604785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How I treat paroxysmal nocturnal hemoglobinuria.
    Brodsky RA
    Blood; 2009 Jun; 113(26):6522-7. PubMed ID: 19372253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement Inhibition in Paroxysmal Nocturnal Hemoglobinuria (PNH): A Systematic Review and Expert Opinion from Central Europe on Special Patient Populations.
    Bodó I; Amine I; Boban A; Bumbea H; Kulagin A; Lukina E; Piekarska A; Zupan IP; Sokol J; Windyga J; Cermak J
    Adv Ther; 2023 Jun; 40(6):2752-2772. PubMed ID: 37072660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of 512 eculizumab-naive paroxysmal nocturnal hemoglobinuria patients in China: a single-center observational study.
    Du Y; Yang Y; Yang C; Chen M; Han B
    Hematology; 2022 Dec; 27(1):113-121. PubMed ID: 35068377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement Inhibitors in the Management of Complement-Mediated Hemolytic Uremic Syndrome and Paroxysmal Nocturnal Hemoglobinuria.
    Begum F; Khan N; Boisclair S; Malieckal DA; Chitty D
    Am J Ther; 2023 May; 30(3):e209-e219. PubMed ID: 37104648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-complement Treatment for Paroxysmal Nocturnal Hemoglobinuria: Time for Proximal Complement Inhibition? A Position Paper From the SAAWP of the EBMT.
    Risitano AM; Marotta S; Ricci P; Marano L; Frieri C; Cacace F; Sica M; Kulasekararaj A; Calado RT; Scheinberg P; Notaro R; Peffault de Latour R
    Front Immunol; 2019; 10():1157. PubMed ID: 31258525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paroxysmal nocturnal hemoglobinuria and the age of therapeutic complement inhibition.
    Varela JC; Brodsky RA
    Expert Rev Clin Immunol; 2013 Nov; 9(11):1113-24. PubMed ID: 24168416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eculizumab: a review of its use in paroxysmal nocturnal haemoglobinuria.
    McKeage K
    Drugs; 2011 Dec; 71(17):2327-45. PubMed ID: 22085388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of paroxysmal nocturnal hemoglobinuria in the era of complement inhibitory therapy.
    Parker CJ
    Hematology Am Soc Hematol Educ Program; 2011; 2011():21-9. PubMed ID: 22160008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial.
    Risitano AM; Röth A; Soret J; Frieri C; de Fontbrune FS; Marano L; Alashkar F; Benajiba L; Marotta S; Rozenberg I; Milojevic J; End P; Nidamarthy PK; Junge G; Peffault de Latour R
    Lancet Haematol; 2021 May; 8(5):e344-e354. PubMed ID: 33765419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paroxysmal nocturnal hemoglobinuria and the complement system: recent insights and novel anticomplement strategies.
    Risitano AM
    Adv Exp Med Biol; 2013; 735():155-72. PubMed ID: 23402025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paroxysmal nocturnal haemoglobinuria at Oslo University Hospital 2000-2010.
    Nissen-Meyer LS; Tjønnfjord GE; Golebiowska E; Kjeldsen-Kragh J; Akkök ÇA
    Tidsskr Nor Laegeforen; 2015 Jun; 135(11):1039-43. PubMed ID: 26080779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.